The aim of this study was to compare the disease characteristics and outcomes of acute icatibant‐treated angioedema attacks between patients with HAE‐nC1 INH in Grenoble center (France) and patients with HAE with C1 INH deficiency (type I) or dysfunction (type II) in the French population. Here, COL18A1 is linked to hereditary angioedema.